| 11773051 | Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. | J Biol Chem | 2002 Mar 22 | Shields JM | - |
| 23331552 | Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer. | Cancer Sci | 2013 Apr | Zhou L | doi: 10.1111/cas.12107 |
| 24476357 | Transgelins, cytoskeletal proteins implicated in different aspects of cancer development. | Expert Rev Proteomics | 2014 Apr | Dvorakova M | doi: 10.1586/14789450.2014.860358 |
| 19848416 | Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. | J Proteome Res | 2009 Dec | Rho JH | doi: 10.1021/pr900705r. |
| 22245152 | Hypoxia-induced SM22α in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy. | FEBS Lett | 2012 Feb 17 | Kim TR | doi: 10.1016/j.febslet.2011.12.036 |
| 26847345 | Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility. | BMC Cancer | 2016 Feb 4 | Zhou HM | doi: 10.1186/s12885-016-2105-8. |
| 20336793 | Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. | Cancer | 2010 Jun 1 | Yeo M | doi: 10.1002/cncr.25003. |
| 19329940 | Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. | Mod Pathol | 2009 Jun | Zhao L | doi: 10.1038/modpathol.2009.29 |
| 19724680 | Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. | Neoplasia | 2009 Sep | Lin Y | - |
| 20012321 | Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer. | Cell Tissue Res | 2010 Feb | Prasad PD | doi: 10.1007/s00441-009-0902-y |
| 21092460 | [Expression of SM22α and its relationship with lymph node metastasis in breast cancer]. | Zhonghua Yi Xue Za Zhi | 2010 Sep 28 | MA ZF | - |
| 17082327 | Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. | Mol Endocrinol | 2007 Feb | Yang Z | - |
| 24657443 | Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. | Biochem Biophys Res Commun | 2014 Apr 18 | Sahasrabuddhe NA | doi: 10.1016/j.bbrc.2014.03.017 |
| 28058861 | Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. | Exp Biol Med (Maywood) | 2017 Mar | Aikins AR | doi: 10.1177/1535370216685435 |
| 26934553 | Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes. | Oncotarget | 2016 Apr 12 | Webber JP | doi: 10.18632/oncotarget.7716. |
| 27270312 | Quantitative proteomics reveals that distant recurrence-associated protein R-Ras and Transgelin predict post-surgical survival in patients with Stage III colorectal cancer. | Oncotarget | 2016 Jul 12 | Xu L | doi: 10.18632/oncotarget.9701. |
